ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
P0125 A phase 1/2 trial of BNC105P with everolimus in metastatic renal cell carcinoma
European Journal of Cancer
◽
10.1016/j.ejca.2015.06.078
◽
2015
◽
Vol 51
◽
pp. e26
Author(s):
S. Pal
◽
A. Azad
◽
S. Bhatia
◽
H. Drabkin
◽
B. Costello
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase 1
Download Full-text
Related Documents
Cited By
References
A phase 1 trial of SGN‐CD70A in patients with CD70‐positive, metastatic renal cell carcinoma
Cancer
◽
10.1002/cncr.31912
◽
2019
◽
Vol 125
(7)
◽
pp. 1124-1132
◽
Cited By ~ 6
Author(s):
Sumanta K. Pal
◽
Andres Forero‐Torres
◽
John A. Thompson
◽
John C. Morris
◽
Saurabh Chhabra
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase 1
◽
Phase 1 Trial
Download Full-text
4513 POSTER Phase 1/2 study of sunitinib in combination with gefitinib in patients (pts) with metastatic renal cell carcinoma (mRCC)
European Journal of Cancer Supplements
◽
10.1016/s1359-6349(07)71144-8
◽
2007
◽
Vol 5
(4)
◽
pp. 302
Author(s):
B.G. Redman
◽
G.R. Hudes
◽
G.V. Kondagunta
◽
P.H. Patel
◽
S.T. Kim
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase 1
Download Full-text
Lenvatinib in combination with everolimus in patients with advanced or metastatic renal cell carcinoma: A phase 1 study
International Journal of Urology
◽
10.1111/iju.13776
◽
2018
◽
Vol 25
(11)
◽
pp. 922-928
◽
Cited By ~ 6
Author(s):
Nobuaki Matsubara
◽
Yoichi Naito
◽
Kenji Nakano
◽
Yutaka Fujiwara
◽
Hiroki Ikezawa
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase 1
◽
Phase 1 Study
Download Full-text
Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma
Cancer Immunology Immunotherapy
◽
10.1007/s00262-018-2248-3
◽
2018
◽
Vol 68
(2)
◽
pp. 319-329
◽
Cited By ~ 4
Author(s):
Charlotte M. Huijts
◽
◽
Inge M. Werter
◽
Sinéad M. Lougheed
◽
Ruben S. Goedegebuure
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Low Dose
◽
Phase 1
◽
Oral Cyclophosphamide
◽
Phase 1 Study
◽
Dose Oral
Download Full-text
Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma
Cancer
◽
10.1002/cncr.26429
◽
2011
◽
Vol 118
(7)
◽
pp. 1868-1876
◽
Cited By ~ 80
Author(s):
Ana M. Molina
◽
Darren R. Feldman
◽
Martin H. Voss
◽
Michelle S. Ginsberg
◽
Michael S. Baum
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase 1
◽
Phase 1 Trial
Download Full-text
Anti-VEGFR, PDGFR, and CSF1R tyrosine kinase inhibitor CM082 (X-82) in combination with everolimus for treatment of metastatic renal cell carcinoma: a phase 1 clinical trial
The Lancet Oncology
◽
10.1016/s1470-2045(17)30764-7
◽
2017
◽
Vol 18
◽
pp. S8
◽
Cited By ~ 2
Author(s):
Xieqiao Yan
◽
Xinan Sheng
◽
Bixia Tang
◽
Zhihong Chi
◽
Chuanliang Cui
◽
...
Keyword(s):
Clinical Trial
◽
Renal Cell Carcinoma
◽
Tyrosine Kinase
◽
Tyrosine Kinase Inhibitor
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Kinase Inhibitor
◽
Phase 1
◽
Phase 1 Clinical Trial
Download Full-text
Phase 1 Trial of Allogeneic Gene-Modified Tumor Cell Vaccine RCC-26/CD80/IL-2 in Patients with Metastatic Renal Cell Carcinoma
Human Gene Therapy
◽
10.1089/hum.2008.192
◽
2010
◽
Vol 21
(3)
◽
pp. 285-297
◽
Cited By ~ 12
Author(s):
Alexander Buchner
◽
Heike Pohla
◽
Gerald Willimsky
◽
Bernhard Frankenberger
◽
Ronald Frank
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Tumor Cell
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase 1
◽
Cell Vaccine
◽
Tumor Cell Vaccine
◽
Phase 1 Trial
Download Full-text
82. A Phase 1-2 Clinical Study of MGN1601, a Tumor Vaccine Comprising Allogeneic, Gene-Modified and Irradiated Tumor Cells in Combination with an Immunomodulator, in Patients with Metastatic Renal Cell Carcinoma (ASET Study) – Preliminary Results
Molecular Therapy
◽
10.1016/s1525-0016(16)36654-0
◽
2011
◽
Vol 19
◽
pp. S33
Keyword(s):
Renal Cell Carcinoma
◽
Clinical Study
◽
Cell Carcinoma
◽
Tumor Cells
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Tumor Vaccine
◽
Phase 1
◽
Preliminary Results
Download Full-text
Phase 1 dose-escalation trial of tremelimumab plus sunitinib in patients with metastatic renal cell carcinoma
Cancer
◽
10.1002/cncr.25639
◽
2010
◽
Vol 117
(4)
◽
pp. 758-767
◽
Cited By ~ 126
Author(s):
Brian I. Rini
◽
Mark Stein
◽
Pat Shannon
◽
Simantini Eddy
◽
Allison Tyler
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Dose Escalation
◽
Renal Cell
◽
Phase 1
Download Full-text
Results of a Phase 1/2 Study in Metastatic Renal Cell Carcinoma Patients Treated with a Patient-specific Adjuvant Multi-peptide Vaccine after Resection of Metastases
European Urology Focus
◽
10.1016/j.euf.2017.09.009
◽
2019
◽
Vol 5
(4)
◽
pp. 604-607
◽
Cited By ~ 4
Author(s):
Steffen Rausch
◽
Cécile Gouttefangeas
◽
Jörg Hennenlotter
◽
Karoline Laske
◽
Kerstin Walter
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase 1
◽
Peptide Vaccine
◽
Patient Specific
◽
Resection Of Metastases
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close